How to Buy Balchem Stock
Balchem Corp
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally.
Balchem stock last closed at $156.92, down 2.84% from the previous day, and has increased 9.18% in one year. It has overperformed other stocks in the Specialty Chemicals industry by 0.24 percentage points. Balchem stock is currently +13.97% from its 52-week low of $137.69, and -15.65% from its 52-week high of $186.03.
As of Apr 21, 2025, there are 32.53M shares of BCPC outstanding. The market cap of BCPC is $5.11B. In the past 24 hours, 120,892 BCPC shares were traded.
How to Buy Balchem Stock
Wondering how to invest in Balchem stock? Here's how.
- Figure out where to buy Balchem stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Balchem stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit money your brokerage account: Pick your payment method and add your info.
- Evaluate Balchem stock: The Balchem ticker symbol is BCPC. Is Balchem stock a good investment? Should you buy shares of BCPC? How do BCPC's underlying business fundamentals look? Do top analysts think Balchem is a good buy? Why has BCPC's stock price moved recently? (Hint: Our stock market research website can help you decide if BCPC is a good stock to buy).
- Make your BCPC purchase: Decide if you will purchase BCPC shares at the current market price or use a limit order to purchase BCPC stock at a given price.
- Get the latest scoop on your investment in BCPC: Create a watchlist to get live updates on your new investment in Balchem stock.
Step 1: Figure out where to buy Balchem stock
You will need an online brokerage account to access the NASDAQ market and buy BCPC shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Tech to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected the best brokerage, you need to fill out some personal details so you can invest in BCPC stock today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to create a new brokerage account.
- Submit your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've finished signing up on one of the best stock trading apps, you need to deposit funds:
Check out this video walkthrough to see the process of transferring money into your brokerage account.
Step 4: Evaluate Balchem stock
After you have decided on the best place to buy Balchem stock, it's very important to research their stock before you invest, so you actually understand the risk and opportunity.
Overview of key BCPC info
Fundamentals of BCPC
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on BCPC's stock page.
How is BCPC stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge BCPC's fair value.
Using relative valuations ratios:
- BCPC may be overvalued based on its P/E ratio of 39.53x, relative to Specialty Chemicals industry P/E ratio of 26.67x
- BCPC could be overvalued based on its P/B ratio of 4.44x, relative to Specialty Chemicals industry P/B ratio of 3.07x
- BCPC may be overvalued based on its PEG ratio of 1.71x
You can access more valuation analysis on BCPC's stock here.
BCPC Financial Summary
Signs that BCPC is financially healthy:
- There are more short-term assets than short-term liabilities on the BCPC balance sheet.
- There are more short-term assets than long-term liabilities on the BCPC balance sheet.
- Total BCPC debt is lower than 5 years ago, relative to shareholder equity.
- BCPC's operating cash flow of $182.00M allows it to safely service it's debt of $208.04M.
- BCPC has a low debt to equity ratio of 0.37.
- BCPC profit margin has gone up from 11.8% to 13.5% in the past year.
- BCPC earnings of $182.98M is not sufficient to cover its interest payments.
Is it a good time to buy BCPC stock, according to Wall Street analysts?
Out of 1 Wall Street analysts who monitor BCPC, the consensus analyst rating on Balchem is a Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Balchem stock forecast page.
BCPC Technicals
BCPC Growth Numbers
Last year, BCPC earnings were $128.48M. During the last 5 year, BCPC's earnings have increased by 9.87% per year. This was slower than the Specialty Chemicals industry average of 14.94%.
Last year, BCPC revenue was $953.68M. In the last five year, BCPC's revenue has increased by 8.18% per year. This was faster than the Specialty Chemicals industry average of 4.61%.
Find out more about BCPC's earnings and revenue performance here.
Are BCPC executives and large shareholders buying or selling the stock?
Over the past year, insiders at BCPC have sold more shares than they have bought.
William A. Backus, VP Chief Accounting Officer of BCPC, was the latest BCPC insider to sell. They sold $175,049.22 worth of BCPC stock on Feb 13, 2025.
Dig into more about who owns BCPC shares here.
Can I get consistent income from BCPC stock?
No, Balchem doesn't provide an income stream by paying out dividends.
What others are saying about BCPC
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your BCPC purchase
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally the best for newer investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a particular price, use a limit order.
Press the Open button and eToro will place your order.
If you require additional info about buying stocks on eToro, watch the how to video below:
Step 6: Get the latest scoop on your investment in BCPC
Now that you own some BCPC shares, you'll want to keep up with your new investment.
Add BCPC to a watchlist to track your BCPC stock.
BCPC Feed
How to Buy Stock in Balchem
To reiterate, here are the 6 steps for buying Balchem stock:
- Figure out where to buy Balchem stock
- Open your brokerage account
- Deposit money your brokerage account
- Evaluate Balchem stock
- Make your BCPC purchase
- Get the latest scoop on your investment in BCPC
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep an eye on your investment in Balchem, create a watchlist today.
More Articles You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.